http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022265673-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcb0dde0aefda78540321dfccbddb40a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2022-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e68eb599338c2e5621773058e9a97582
publicationDate 2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022265673-A1
titleOfInvention Combination therapy
abstract Provided herein are methods of treating diseases, such as cancer, using a combination therapy. In certain embodiments, the methods comprise administering an effective amount of a phosphoinositide-3-kinase (PI3K) inhibitor and an effective amount of a CD20 inhibitor to a patient.
priorityDate 2017-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012252802-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422340563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422340586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449130091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422340557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167692484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167695159
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478703188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478753582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471645853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167635494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478750018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478633234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478569152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471627723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478676404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571132
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158316769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414303395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408208514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471645829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167708594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167656451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471645828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408538801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422340592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411864003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167545428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167600671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422340596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422340556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66571071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID478771420

Total number of triples: 71.